Skip to main content

Table 1 Baseline demographics of patients in the Colorado MOUD Pilot Program

From: Outcomes from the medication assisted treatment pilot program for adults with opioid use disorders in rural Colorado

Characteristic

Non-Evaluable a N (%)

Evaluable N (%)

P

Gender

N = 723

N = 174

.21

 Female

341 (47.2)

86 (48.6)

 

 Male

368 (50.9)

87 (49.2)

 

 Other

1 (0.1)

1 (0.1)

 

Race/Ethnicity

N = 723

N = 177

.33

 White non-Hispanic

368 (50.9)

101 (57.0)

 

 Hispanic

310 (42.9)

65 (36.7)

 

 Other

24(1.0)

11 (4.0)

 

Age

N = 714

N = 176

.06

 18–24 yrs. old

96 (13.3)

19 (10.7)

 

 25–34 yrs. old

302 (41.8)

69 (39.0)

 

 35–44 yrs. old

189 (26.1)

40 (22.6)

 

 45–54 yrs. old

88 (12.2)

28 (15.8)

 

 55–64 yrs. old

32 (4.4)

17 (9.6)

 

 Over 65 yrs. old

7 (0.9)

3 (1.7)

 

Health Insurance

N = 363

N = 171

.53

 Medicaid only

278 (76.6)

136 (83.4)

 

 Medicare only

12 (3.3)

10 (6.1)

 

 Medicaid + Medicare

15 (4.1)

6 (3.5)

 

 Private

24 (6.6)

8 (4.7)

 

 Other

7 (1.9)

0 (0)

 

 None

27 (7.4)

8 (4.5) P

 

Employment in the last 3 yrs

N = 362

N = 168

.37

 Full time

101 (27.9)

57 (32.8)

 

 Part time

71 (19.6)

25 (14.5)

 

 Unemployed

190 (52.5)

91 (52.6)

 

Marital status

N = 364

N = 171

.77

 Married

73 (20.3)

36 (21.0)

 

 Widowed, Separated, or Divorced

107 (29.4)

58 (33.9)

 

 Never Married

184 (50.5)

77 (45.0)

 

Previous treatment

 No previous OUD treatment

120 (33.1)

47(27.3)

.67

Reason to start treatmentb

N = 355–553

N = 167–183

 

 Self-motivation

453 (82.0)

151(83.1)

.87

 Court-order

56 (14.1)

12 (7.1)

P < .01

 On parole or probation

93 (25.2)

19 (11.1)

P < .01

  1. Demographics describe patient characteristics at the start of treatment (n = 190) collected by three participating rural clinical sites. Missing data due to lack of self-reporting varied by item, from ~ 6% for age and race/ethnicity to > 50% for employment or substance use specification; actual counts per variable are noted
  2. a Evaluable patients are those who started the MOUD treatment and completed both baseline and follow-up surveys, as contrast with non-evaluable patients had an induction but withdrew or were lost to follow-up and thus did not have follow-up data regarding substance use. b Reasons for start treatment are all independent variables and do not add up to 100%